- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
X
XTLB
Xtl Biopharmaceu
1.51
-0.12-7.36%Closed13:33 07/16 EDT
OPEN/PREV CLOSE1.509/1.630
TODAY RANGE1.509-1.710
VOL10.69K
MARKET CAP13.31M
52 WEEK RANGE0.8600-3.050
AVG VOL (3M)34.89K
% TURNOVER0.12%
TURNOVER--
P/E (TTM)-9.8952
% RANGE12.36%
EPS(TTM)-0.1526
P/E(FORWARD)-6.6600
P/B2.449
BVPS0.6166
DIVIDEND--
P/S29.49
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.81M
SHARES OUTSTANDING8.81M
NEXT EARNINGS--
FREE FLOAT5.17M
LOT SIZE1
EX-DATE02/10/2017
News
Press Releases
Financial Reports
Profile
Benzinga·07/07 10:26
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Benzinga·06/25 21:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga·06/25 12:09
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·06/25 09:43
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga·06/24 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·06/13 21:41
XTL Biopharmaceuticals Announces Shareholder Meeting for Key Decisions
TipRanks·04/07 13:20
XTL Biopharmaceuticals appoints Noam Band as CEO
Benzinga·03/27 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
TipRanks·03/04 11:47
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil
TipRanks·02/03 21:29
XTL Biopharmaceuticals Adjusts Board Representation Amid Resignations
TipRanks·12/31/2024 01:17
XTL Biopharmaceuticals Expands Portfolio with Social Proxy Acquisition Amidst Regional Challenges
TipRanks·12/31/2024 01:17
XTL Biopharmaceuticals Reports Financial Results Amid Regional Unrest
Same Industry
Name/Symbol
Change%
Price